FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for GONAL-F RFF REDI-JECT, a redesigned auto-injector formulation of follitropin alfa, expanding the GONAL-F product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism
• Infertility

Drugs mentioned

• GONAL-F RFF REDI-JECT (Follitropin)

Snippet

SUPPL AP for GONAL-F RFF REDI-JECT (FOLLITROPIN)